Completed PHASE3 INTERVENTIONAL 4-arm NCT00000479

Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer (WHS)

Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women

Sponsor: Brigham and Women's Hospital

Conditions Cardiovascular Diseases Cerebrovascular Disorders Coronary Disease Heart Diseases Myocardial Infarction Myocardial Ischemia Vascular Diseases

Interventions Aspirin Placebo Vitamin E

Updated 7 times since 2017 Last updated: Jun 12, 2012 Started: Sep 30, 1992 Primary completion: Mar 31, 2004 Completion: Feb 28, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000479, this PHASE3 trial focuses on Cardiovascular Diseases and Cerebrovascular Disorders and remains completed. Sponsored by Brigham and Women's Hospital, it has been updated 7 times since 1992, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3
Jan 2021 — Dec 2022 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brigham and Women's Hospital
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)

Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.